PrognomiQ
Latest round
- Series D
Last raised
- Aug 2024
Total raised
- $136M
Investors
- 10
About PrognomiQ
PrognomiQ, Inc.Founded in 2020 in San Mateo, US, PrognomiQ, Inc. is engaged in the development of advanced diagnostic tools.PrognomiQ specializes in developing innovative multi-omics platforms focused on early disease detection and treatment, targeting complex diseases such as cancer. Their core products include proprietary proteomic data generation systems that analyze protein molecules deeply to derive insights into an individual's biological state. This data is integrated with genomic and metabolomic information to create testing products that provide healthcare professionals with actionable insights aimed at improving patient outcomes.PrognomiQ's revenue model is based on the sale of multi-omics testing products and services to healthcare providers and research institutions. The company operates through B2B transactions, forming partnerships with hospitals and clinics utilizing their diagnostic tools. Their transaction structures include direct sales agreements and subscription models for ongoing access to their testing platforms, with flagship products designed to enhance early disease detection capabilities.In August 2024, PrognomiQ, Inc. The company plans to expand its product lineup with new testing solutions targeting additional complex diseases, aiming for launches in 2025. Furthermore, PrognomiQ is looking to enter new markets in Asia and Europe by 2025, enhancing its presence in regions where personalized medicine is gaining traction.
Who invested in PrognomiQ
10 investors across 3 rounds
See all investors in PrognomiQ
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about PrognomiQ
Who invested in PrognomiQ?
PrognomiQ has 10 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has PrognomiQ raised?
PrognomiQ has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did PrognomiQ last raise money?
PrognomiQ's most recent round on record is a Series D, in Aug 2024.
What does PrognomiQ do?
PrognomiQ is a biotechnology company.
Where is PrognomiQ headquartered?
PrognomiQ is headquartered in San Mateo, US.
Which VCs invest in companies like PrognomiQ?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at PrognomiQ's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like PrognomiQ? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.